In September 2025, EY published its 19th ‘Pulse of the Medtech Industry’ report. Authored by John Babitt, EY’s global medtech leader, and Arda Ural, EY Americas life sciences leader, the report highlighted that the medtech industry has been experiencing steady VC and M&A activity, with deal-making “judicious”, with less deals being made yet ones with higher valuations overall. Medical Device Network spoke to Babitt to learn what impact rising challenges such as investor perception, conflict in the Middle East, and Iran’s closure of the Strait of Hormuz are having on factors such as pricing and IPO activity in the medtech industry.
Read the full article: EY on the Current State of the Medtech Industry //
Source: https://www.medicaldevice-network.com/interviews/ey-on-the-current-state-of-the-medtech-industry/